Journal of Archives in Military Medicine

Published by: Kowsar

The Value of Exercise Stress Testing for Renal-Cardiac Risk Assessment in Military Personnel: Exploring the Hidden Half!

Ali Reza Khoshdel 1 , * , Habib Mirzababaie 2 and Hooman Angoorani 3
Authors Information
1 Epidemiology Research Centre, Aja University of Medical Sciences, Tehran, IR Iran
2 Air Force General Hospital, Aja University of Medical Sciences, Tehran, IR Iran
3 Department of Sports Medicine, Hazrat Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Archives in Military Medicine: March 01, 2014, 2 (1); e17271
  • Published Online: February 4, 2014
  • Article Type: Review Article
  • Received: January 15, 2014
  • Accepted: January 21, 2014
  • DOI: 10.5812/jamm.17271

To Cite: Khoshdel A R, Mirzababaie H, Angoorani H. The Value of Exercise Stress Testing for Renal-Cardiac Risk Assessment in Military Personnel: Exploring the Hidden Half!, J Arch Mil Med. 2014 ; 2(1):e17271. doi: 10.5812/jamm.17271.

Abstract
Copyright © 2014, AJA University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. An Overview of Exercise Test
3. Diagnostic Value of Exercise Test
4. Hemodynamic Response to Exercise
5. Exercise-Induced Albuminuria
6. Assessment of Arterial Stiffness
7. Epidemiologic Aspects of Cardiac Stress Test
8. Exercise Stress Test in Military Forces
9. Conclusions
Acknowledgements
Footnotes
References
  • 1. Clinical exercise stress testing. Safety and performance guidelines. The Cardiac Society of Australia and New Zealand. Med J Aust. 1996; 164(5): 282-4[PubMed]
  • 2. Freedman B. Safety and performance guidelines for clinical exercise stress testing 2003;
  • 3. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002; 105(10): 1202-7[PubMed]
  • 4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131): 837-53[PubMed]
  • 5. Gibbons RJ, Antman EM. ACC/AHA 2002 Guideline Update For Exercise Testing. ACC/AHA Practice Guidelines. 2002;
  • 6. Crawford MH. Diagnostic studies in cardiology. 2003;
  • 7. Zipes DP, Libby P, Bonow RO. Braunwald's Heart Disease. 2005;
  • 8. Eisenberg JM, Hutton JJ, Klippel JH, Kohler PO, et al . Internal Medicine. 1998;
  • 9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001; 285(19): 2486-97[PubMed]
  • 10. Dunbar CC, Saul BI, Kassotis J, Badillo L. Usefulness of P-wave morphology during submaximal treadmill exercise to predict coronary artery disease. Am J Cardiol. 2005; 96(6): 781-3[PubMed]
  • 11. American Thoracic Society , American College of Chest Physicians . ATS/ACCP Statement on cardiopulmonary exercise testing. Am JRespir Crit Care Med. 2003; 167(2): 211-77
  • 12. Lepretre PM, Foster C, Koralsztein JP, Billat VL. Heart rate deflection point as a strategy to defend stroke volume during incremental exercise. J appl Physiol. 2005; 98(5): 1660-5
  • 13. Lauer MS. Exercise electrocardiogram testing and prognosis. Novel markers and predictive instruments. Cardiol Clin. 2001; 19(3): 401-14
  • 14. Chung EK, Tighe DA. Stress Testing. 1997;
  • 15. Pescatello LS, Franklin BA, Fagard R. American College of Sports Medicine position stand. Exercise and hypertension. MedSci Sports Exerc 2004; 36(3): 533-53
  • 16. Amon KW, Richards KL, Crawford MH. Usefulness of the postexercise response of systolic blood pressure in the diagnosis of coronary artery disease. Circulation. 1984; 70(6): 951-6
  • 17. McHam SA, Marwick TH, Pashkow FJ, Lauer MS. Delayed systolic blood pressure recovery after graded exercise: an independent correlate of angiographic coronary disease. J Am Coll Cardiol. 1999; 34(3): 754-9
  • 18. Abidov A, Rozanski A, Hachamovitch R, Hayes SW, Aboul-Enein F, Cohen I, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med. 2005; 353(18): 1889-98[PubMed]
  • 19. Berne RM, Levy MN. Physiology. 1998;
  • 20. Laragh JH, Brenner BM. Hypertension: Pathophysiology, Diagnosis and Management. 1995;
  • 21. Khan JK, Zola B, Juni JE. Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care. 1986; 9(4): 389-94
  • 22. Bernardi L. Clinical evaluation of arterial baroreflex activity in diabetes. Diabet Nutr Metabol Clin Experiment 2000; 13(6): 331-40
  • 23. Stewart KJ, Sung J, Silber HA, et al . Exaggerated Exercise Blood Pressure is related to impaired endothelial vasodilator function. Am J Hypertens. 2004; 17(4): 314-20
  • 24. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9(3): 237-52[PubMed]
  • 25. Poirier P, Garneau C, Bogaty P. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well controlled type 2 diabetes mellitus. Am J Cardiol. 2000; 85(4): 473-7
  • 26. Bell DSH. Diabetic Cardiomyopathy. Diabetes Care. 2003; 26(10): 2949-50
  • 27. Bacon SL, Lavoie KL, Campbell TS, Fleet R, Arsenault A, Ditto B. The role of ischaemia and pain in the blood pressure response to exercise stress testing in patients with coronary heart disease. J Hum Hypertens. 2006; [PubMed]
  • 28. Yerkey MW, Kernis SJ, Franklin BA. Renal dysfunction and acceleration of coronary disease. Heart. 2004; 90(8): 961-6
  • 29. Mueller C, Neumann FJ, RPerruchoud AP. Renal function and long-term mortality after unstable angina/non-STsegment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention. Heart. 2004; 90(8): 902-7
  • 30. Mircoli L, Rivera R, Giuseppe B. Influence of left ventricular mass, uremia and hypertension on vagal tachycardic reserve. J Hypertens. 2003; 21(8): 1547-53
  • 31. Thambyrajah J, Landray MJ, McGlynn FJ. abnormalities in endothelial function in patients with predialysis renal failure. Heart. 2000; 83(2): 205-9
  • 32. Regensteiner JC, Sipple J, McFarling ET. Effects of non-insulin dependent diabetes mellitus on exercise performance. Med Sci Sports Exerc. 1995; 27(2): 875-81
  • 33. Masuda I, Sato I. Exercise testing clinical and angiographic characteristics of anginal patients with and without diabetes mellitus. Angiology. 1989; 40(7): 656-65
  • 34. Disturbed Hemodynamic Cardiac Exercise Stress Test Reponse in non-smoking, Normolipidemic, Normotensive Diabetic Subjects. Cardiovascular disease in the 21st century: Shaping the future
  • 35. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999; 281(6): 524-9[PubMed]
  • 36. Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology. 2005; 104(4): 221-6[PubMed]
  • 37. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1995; 91(2): 580-615[PubMed]
  • 38. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978; 57(3): 549-56[PubMed]
  • 39. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care. 2005; 28(10): 2525-30[PubMed]
  • 40. Estacio RO, Regensteiner JG, Wolfel EE. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care. 1998; 21(2): 291-5
  • 41. Kelbaek H, Jensen T. Impaired left ventricular function in IDDM patients with increased urinary albumin excretion. Scand J Clin Lab Invest. 1991; 51: 467-73
  • 42. Sampson MJ, Chambers JB. Abnormal diastolic function in patients with type 1 diabetes and early nephropathy. British Heart Journal. 1990; 64: 266-71
  • 43. Rutter MK, Wahid ST, McComb JM, Marshall SM. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2002; 40(1): 56-61[PubMed]
  • 44. Rutter MK, McComb JM, Brady S, Marshall SM. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol. 1999; 83(1): 27-31[PubMed]
  • 45. Al-Attar AT, Mahussain SA, Sadanandan S. Cardiac tests in asymptomatic type 2 diabetics. Med Princ Pract. 2002; 11(4): 171-5[PubMed]
  • 46. Ala-Houhala I. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects. Scand J Clin Lab Invest. 1990; 50(1): 27-33[PubMed]
  • 47. Hidaka S, Kaneko O, Shirai M, Kojima K, Igarashi Y, Oda K, et al. Do obesity and non-insulin dependent diabetes mellitus aggravate exercise-induced microproteinuria? Clin Chim Acta. 1998; 275(2): 115-26[PubMed]
  • 48. Agarwal RP, Thanvi I, Vachhani G, Kochar DK, Rastogi A. Exercise induced proteinuria as an early indicator of diabetic nephropathy. J Assoc Physicians India. 1998; 46(9): 772-4[PubMed]
  • 49. Romanelli G, Giustina A, Cimino A, Valentini U, Agabiti-Rosei E, Muiesan G, et al. Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics. Bmj. 1989; 298(6669): 284-8[PubMed]
  • 50. Christensen CK. Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise. Kidney Int. 1984; 25(5): 819-23[PubMed]
  • 51. Poulsen PL, Ebbehoj E, Mogensen CE. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study. J Intern Med. 2001; 249(5): 433-40[PubMed]
  • 52. Khoshdel AR, Carney SL, Nair BR, Gillies A. Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine. Clin Med Res. 2007; 5(1): 45-52[PubMed]
  • 53. Khoshdel AR, Thakkinstian A, Carney SL, Attia J. Estimation of an age-specific reference interval for pulse wave velocity: a meta-analysis. J Hypertens. 2006; 24(7): 1231-7[PubMed]
  • 54. Khoshdel AR, Carney SL. Arterial stiffness in kidney transplant recipients: an overview of methodology and applications. Urol J. 2008; 5(1): 3-14[PubMed]
  • 55. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens. 2001; 19(3): 381-7[PubMed]
  • 56. Blacher J, Pannier B, Guerin AP, et al . Carotid Arterial Stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998; 32: 570-4
  • 57. Khoshdel AR, Carney SL, Gillies A, Mourad A, Nanra R, Jones B, et al. The impact of diabetes mellitus on arterial stiffness in end-stage renal disease (Abstract). Nephrology. 2005; 10
  • 58. Khoshdel AR, Carney SL, White S. Disturbed hemodynamic cardiac exercise stress test response in non-smoking, normolipidemic, normotensive, diabetic subjects. Diabetes Res Clin Pract. 2006; [PubMed]
  • 59. Cantwell JD, Murray PM, Thomas RJ. Current management of severe exercise-related cardiac events. Chest. 1988; 93(6): 1264-9[PubMed]
  • 60. Rodgers GP, Ayanian JZ, Balady G, Beasley JW, Brown KA, Gervino EV, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing. A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation. 2000; 102(14): 1726-38[PubMed]
  • 61. Zafar-ul-Islam , Waris J, Kango ZA. Use of Exercise Tolerance Test and Thallium Stress Test in the Diagnosis of Ischemic Heart Disease in Soldiers. J College Physician Surg Pakistan. 2009; 19(7): 406-9
  • 62. Yamgushi M, Shimizo M, Ino H. Diagnostic usefullness of the post-exercise systolic blood pressure response for the detection of coronary artery disease in patients with diabetes mellitus. Japan Circulat J 2000; 64(12): 949-52
  • 63. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004; 351(13): 1285-95[PubMed]
  • 64. Moyer VA. Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012; 157
  • 65. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol. 2002; 147(5): 649-54[PubMed]
  • 66. Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002; 25(11): 2032-6[PubMed]
  • 67. Mark DB, Shaw L, Harrell F E Jr.. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991; 325(12): 849-53
  • 68. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005; 352(19): 1951-8[PubMed]
  • 69. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation. 1996; 93(8): 1520-6[PubMed]
  • 70. Hemodynamic Response to Exercise Predicts the Development of Severe Renal Failure 14th World Congress on Heart Disease : 11
  • 71. Hatzfeld JJ, La Veist TA, Gastone-Johnsson FG. Racial/Ethnic Disparities in the Prevalence of Selected Chronic Diseases Among US Air Force Members, 2008. Prev Chronic Dis. 2012; 9: 110136
  • 72. Paris RM, Bedno SA, Krauss MR, et al. . Weighing in on Type 2 Diabetes in the Military. Diabetes Care. 2001; 24: 1894-8
  • 73. Irvani S, Sabayan B, Sedaghat S, Khoshdel AR, et al. . The Association of Elevated Serum Alanine Aminotransferase with Metabolic Syndrome in A Military Population in Southern Iran. Iran Cardiovasc Res J 2010; 4(2): 74-9
  • 74. Khoshdel AR, Seyed Jafari SM, Heydari ST, et al. . The Prevalence of Cardiovascular Disease Risk Factors, and Metabolic Syndrome among Iranian Military Parachutists. Int Cardiovasc Res J. 2012; 6(2): 51-5
  • 75. Kabir MA, Hossain MR, Hague MF, et al. . Prevalence of metabolic syndrome in Army personnel Residing in Bogra Cantonment. JAFMC Bagladesh. 2012; 8(2): 47-51
  • 76. Heydari ST, Khoshdel AR, Sabayan B, Abtahi B. Prevalence of Cardiovascular Risk Factors Among Military Personnel in Southern Iran. Iran Cardiovasc Res J 2010; 4(1): 22-7
  • 77. Varma PP, Raman DK, Ramakrishnan TS, et al . Prevalence of Early Stages of Chronic Kidney Disease in Healthy Army Personnel. MJAFI. 2011; 67: 9-14
  • 78. Knoflach M, Kiechl S, Kind M. Cardiovascular Risk Factors and Atherosclerosis in Young Males: ARMY . Circulation. 2003; 108: 1064-9
  • 79. Grundy SM, Howard B, Smith S Jr., Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002; 105(18): 2231-9[PubMed]
  • 80. Knapp RG, Miller MC. Clinical Epidemiology and Biostatistics. 1992;
  • 81. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004; 110(1): 22-6[PubMed]
  • 82. Casiglia E, Zanette G, Mazza A, Donadon V, Donada C, Pizziol A, et al. Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol. 2000; 16(7): 677-84[PubMed]
  • 83. Tuttle KR, Puhlman ME, Cooney SK, Short R. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study. Am J Kidney Dis. 1999; 34(5): 918-25[PubMed]
  • 84. Raxwal V, Shetler K, Morise A, Do D, Myers J, Atwood JE, et al. Simple treadmill score to diagnose coronary disease. Chest. 2001; 119(6): 1933-40[PubMed]
  • 85. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157(21): 2413-46[PubMed]
  • 86. Richardson MT, Holly RG, Amsterdam EA, Wang MQ. The value of ten common exercise tolerance test measures in predicting coronary disease in symptomatic females. Cardiology. 1995; 86(3): 243-8[PubMed]
  • 87. Eshtiaghi R, Khoshdel A. Serum Melatonin Level Disturbance is Related to Metabolic Syndrome and Subclinical Arterial Dysfunction in Shift Working Healthy Men. Metabol Syndrome Relat Dis. 2013; 2(2): 100128
  • 88. Greenland P, Gaziano JM. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med. 2003; 349(5): 465-73[PubMed]
  • 89. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant. 2002; 1: 50-4[PubMed]
  • 90. Silverberg DS, Wexler D, Blum M. The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant. 2003; 18(1): 141-6
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments